ERS International Congress 2020 virtual: highlights from the Respiratory Intensive Care Assembly
- Camille Rolland-Debord1,
- Alexander D'Haenens2,
- Leire Mendiluce3,
- Lydia Spurr4,
- Shruthi Konda5,
- Radostina Cherneva6,
- Elodie Lhuillier7,
- Leo Heunks8 and
- Maxime Patout9,10⇑
- 1AP-HP, Groupe Hospitalier Universitaire APHP-Sorbonne Université, Service des Explorations Fonctionnelles de la Respiration de l'Exercice et de la Dyspnée, Hôpital Tenon, Paris, France
- 2Departement of Respiratory Medicine, University Hospitals Leuven, Leuven, Belgium
- 3Ventilation Unit and Respiratory Semi-Critical Care Unit, Department of Respiratory Medicine, University Hospital Germans Trias i Pujol, Universitat de Barcelona, Spain
- 4Academic and Clinical Dept of Sleep and Breathing, Royal Brompton and Harefield Hospitals, London, UK
- 5Department of Respiratory Medicine, Royal Brompton Hospital, London, United Kingdom
- 6Medical University, Sofia, Department of Respiratory Diseases, University Hospital ‘St. Sophia’, Sofia, Bulgaria
- 7Unité de recherche clinique, Centre Henri Becquerel, Rouen, Haute-Normandie, France
- 8Department of Intensive Care, Amsterdam University Medical Center, , Amsterdam, the Netherlands
- 9AP-HP, Groupe Hospitalier Universitaire APHP-Sorbonne Université, site Pitié-Salpêtrière, Service des Pathologies du Sommeil (Département R3S), Paris, France
- 10Sorbonne Université, INSERM, UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, Paris, France
- Dr. Maxime Patout, AP-HP, Groupe Hospitalier Universitaire APHP-Sorbonne Université, site Pitié-Salpêtrière, Service des Pathologies du Sommeil (Département R3S), 47-83 Boulevard de l'hôpital, 75013, Paris, France. E-mail: maxime.patout{at}aphp.fr
Abstract
During the virtual European Respiratory Society (ERS) Congress 2020, early career members summarized the sessions organized by the Respiratory Intensive Care Assembly. The topics covered included diagnostic strategies in patients admitted to the Intensive Care unit (ICU) with acute respiratory failure, with a focus on patients with interstitial lung disease and for obvious reasons, SARS-CoV2 infection. These sessions are summarized in this paper, with take-home messages highlighted.
Footnotes
This manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article.
Conflict of interest: Dr. D'Haenens has nothing to disclose.
Conflict of interest: Dr. Mendiluce has nothing to disclose.
Conflict of interest: Dr. Spurr has nothing to disclose.
Conflict of interest: Dr. Konda has nothing to disclose.
Conflict of interest: Dr. Cherneva has nothing to disclose.
Conflict of interest: Dr. Lhuillier has nothing to disclose.
Conflict of interest: Dr. Heunks has nothing to disclose.
Conflict of interest: Dr. Rolland has nothing to disclose.
Conflict of interest: Dr. PATOUT reports personal fees from Resmed, Philips Respironics, grants and non-financial support from Fisher & Paykel, nonfinancial support and personal fees from Asten, research grants from B&D Electromedical and Fisher & Paykel, personal fees and non-financial support from Chiesi outside the submitted work.
This is a PDF-only article. Please click on the PDF link above to read it.
- Received March 25, 2021.
- Accepted August 19, 2021.
- Copyright ©The authors 2021
This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions{at}ersnet.org